107 related articles for article (PubMed ID: 34648686)
1. Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation.
Wang Q; Spenkelink B; Boonpawa R; Rietjens IMCM; Beekmann K
Mol Nutr Food Res; 2020 Mar; 64(6):e1900912. PubMed ID: 32027771
[TBL] [Abstract][Full Text] [Related]
2. Interaction of mycotoxins zearalenone, α-zearalenol, and β-zearalenol with cytochrome P450 (CYP1A2, 2C9, 2C19, 2D6, and 3A4) enzymes and organic anion transporting polypeptides (OATP1A2, OATP1B1, OATP1B3, and OATP2B1).
Kaci H; Dombi Á; Gömbös P; Szabó A; Bakos É; Özvegy-Laczka C; Poór M
Toxicol In Vitro; 2024 Apr; 96():105789. PubMed ID: 38341109
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Zearalenone and Its Metabolites in the Blood of High-Yielding Dairy Cows at Selected Collection Sites in Various Disease States.
Barański W; Gajęcka M; Zielonka Ł; Mróz M; Onyszek E; Przybyłowicz KE; Nowicki A; Babuchowski A; Gajęcki MT
Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34203296
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α interaction of zearalenone and its phase I metabolite α-zearalenol in combination with soy isoflavones in hERα-HeLa-9903 cells.
Grgic D; Novak B; Varga E; Marko D
Mycotoxin Res; 2024 Feb; 40(1):97-109. PubMed ID: 37847468
[TBL] [Abstract][Full Text] [Related]
5. A mechanistic toxicology study to grasp the mechanics of zearalenone estrogenicity: Spotlighting aromatase and the effects of its genetic variability.
Perugino F; Pedroni L; Galaverna G; Dall'Asta C; Dellafiora L
Toxicology; 2024 Jan; 501():153686. PubMed ID: 38036094
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Changes in the Intestinal Microbiome of Gilts Exposed to Low Zearalenone Doses.
Cieplińska K; Gajęcka M; Dąbrowski M; Rykaczewska A; Lisieska-Żołnierczyk S; Bulińska M; Zielonka Ł; Gajęcki MT
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31137638
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic, androgenic, and genotoxic activities of zearalenone and deoxynivalenol in in vitro bioassays including exogenous metabolic activation.
Yu M; Oskarsson A; Alexander J; Lundqvist J
Mycotoxin Res; 2024 Apr; ():. PubMed ID: 38587710
[TBL] [Abstract][Full Text] [Related]
8. Zearalenone-14-glucoside specifically promotes dysplasia of Gut-Associated Lymphoid Tissue: A natural product for constructing intestinal nodular lymphatic hyperplasia model.
Ruan H; Wang Y; Zhang J; Huang Y; Yang Y; Wu C; Guo M; Luo J; Yang M
J Adv Res; 2023 Oct; 52():135-150. PubMed ID: 37230382
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites.
Stevanoska M; Folz J; Beekmann K; Aichinger G
Toxicol Lett; 2024 May; 396():94-102. PubMed ID: 38685289
[TBL] [Abstract][Full Text] [Related]
10. A Cohort Study Investigating Zearalenone Concentrations and Selected Steroid Levels in Patients with Sigmoid Colorectal Cancer or Colorectal Cancer.
Lisieska-Żołnierczyk S; Gajęcka M; Dąbrowski M; Zielonka Ł; Gajęcki MT
Toxins (Basel); 2023 Dec; 16(1):. PubMed ID: 38251232
[TBL] [Abstract][Full Text] [Related]
11. 27-Hydroxycholesterol/liver X receptor/apolipoprotein E mediates zearalenone-induced intestinal immunosuppression: A key target potentially linking zearalenone and cancer.
Ruan H; Zhang J; Wang Y; Huang Y; Wu J; He C; Ke T; Luo J; Yang M
J Pharm Anal; 2024 Mar; 14(3):371-388. PubMed ID: 38618245
[TBL] [Abstract][Full Text] [Related]
12. Kinetics, Thermodynamics and Mechanism of Enzymatic Degradation of Zearalenone in Degummed Corn Oil.
Zhao C; Xie P; Jin J; Jin Q; Wang X
Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668839
[TBL] [Abstract][Full Text] [Related]
13. ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.
Li H; Bunglawala F; Hewitt NJ; Pendlington R; Cubberley R; Nicol B; Spriggs S; Baltazar M; Cable S; Dent M
Toxicol Sci; 2023 Oct; 196(1):1-15. PubMed ID: 37584694
[TBL] [Abstract][Full Text] [Related]
14. Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies.
Punt A; Pinckaers N; Peijnenburg A; Louisse J
Chem Res Toxicol; 2021 Feb; 34(2):460-472. PubMed ID: 33382582
[TBL] [Abstract][Full Text] [Related]
15. In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids.
Alhejji Y; Widjaja F; Tian S; Hoekstra T; Wesseling S; Rietjens IMCM
Curr Res Toxicol; 2024; 6():100160. PubMed ID: 38469320
[TBL] [Abstract][Full Text] [Related]
16. Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays.
van Tongeren TCA; Wang S; Carmichael PL; Rietjens IMCM; Li H
Arch Toxicol; 2023 Jun; 97(6):1547-1575. PubMed ID: 37087486
[TBL] [Abstract][Full Text] [Related]
17. PBK Model-Based Prediction of Intestinal Microbial and Host Metabolism of Zearalenone and Consequences for its Estrogenicity.
Mendez-Catala DM; Wang Q; Rietjens IMCM
Mol Nutr Food Res; 2021 Dec; 65(23):e2100443. PubMed ID: 34648686
[TBL] [Abstract][Full Text] [Related]
18. An
Mendez-Catala DM; Spenkelink A; Rietjens IMCM; Beekmann K
Toxicol Rep; 2020; 7():938-946. PubMed ID: 32793423
[TBL] [Abstract][Full Text] [Related]
19. Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults.
Ali N; Degen GH
Arch Toxicol; 2018 Aug; 92(8):2691-2700. PubMed ID: 29980802
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
